LIFE, US0021202025

aTyr Pharma stock: Investor conferences set for November and December

Published on 11/13/2026 at 22:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

aTyr Pharma stock gets two scheduled investor appearances in November and December. CEO Sanjay S. Shukla will host a December 3 fireside chat.

Upcoming investor conferences

aTyr Pharma will hold investor meetings at the Jefferies Global Healthcare Conference in London on November 17-18, 2026.
Chief Executive Officer Sanjay S. Shukla is scheduled to lead a fireside chat at the Piper Sandler Healthcare Conference on December 3, 2026.
The company is developing efzofitimod for interstitial lung disease and other therapies for fibrosis and inflammation.

LIFE, US0021202025, Illustration mit AI erstellt.

aTyr Pharma announced on November 11, 2026 that it will participate in two upcoming healthcare investor conferences. The company outlined the schedule in a release carried by BioSpace.

Two appearances are scheduled

aTyr will take part in one-on-one investor meetings at the Jefferies Global Healthcare Conference in London on Tuesday, November 17, and Wednesday, November 18. The company did not announce a public presentation format for those meetings.

At the Piper Sandler 38th Annual Healthcare Conference in New York, Chief Executive Officer Sanjay S. Shukla is scheduled to participate in a fireside chat on Thursday, December 3, at 2:00 p.m. Eastern Time. Management will also be available for one-on-one meetings with registered attendees.

Pipeline remains the business backdrop

aTyr is a clinical-stage biotechnology company developing therapies for fibrosis and inflammation. Its lead candidate, efzofitimod, is in clinical development for interstitial lung disease, including pulmonary sarcoidosis and systemic sclerosis-related interstitial lung disease.

The Piper Sandler event will be webcast through the company's investor website, with a replay expected to remain available for at least 90 days after the presentation.